Speaker Profile

Ph.D., CEO, BioMADE

Biography
Douglas Friedman is CEO of BioMADE, the Bioindustrial Manufacturing Innovation Institute. His interests lie in the fields of synthetic biology, bioindustrial manufacturing, and biotechnology as they relate to the development of the bioeconomy. He is a subject matter expert on emerging biotechnologies, biotechnology policy, and related national security topics. He is a member of several advisory groups including the Department of Commerce, Bureau of Industry & Security Materials and Equipment Technical Advisory Committee. Prior to BioMADE, Doug was the inaugural Executive Director of Engineering Biology Research Consortium (EBRC) and currently serves on its Steering Committee. He earned a Ph.D. in Chemistry from Northwestern University and a B.S. in Chemical Biology from the University of California, Berkeley.


 Session Abstract – PMWC 2023 Silicon Valley

Track 4 - January 25 9.00 A.M.-4.45 P.M.


Track Chair: Cindy Lawley, Olink

  • How New Public-Private Collaboratives Can Catalyze Transformative Health Breakthroughs
    Chair: Keith Yamamoto, UCSF
    - Douglas Friedman, Engineering Biology Research Consortium (EBRC)
    - Jay Keasling, JBEI (Joint BioEnergy Institute)
    - Renee Wegrzyn, ARPA-H
  • Moving Sequencing into the Clinical Setting
    Chair: Charles Chiu, UCSF
    - Charlotte Hobbs, Rady Children’s Hospital
    - Euan Ashley, Stanford University
    - Sivan Bercovici, Karius
    - Heike Sichtig, Foundation Medicine
  • Evolving Sequencing Applications: Spatial Single-Cell Multi-Omics
    Chair: Michael Rhodes, NanoString
    - Chrstina Curtis, Stanford
  • How will Cheap Genome Sequencing Impact Genomic Medicine (PANEL)
    Chair: Euan Ashley, Stanford
    - Shawn Levy, Element Biosciences
    - Aleks Rajkovic, UCSF
    - David Bentley, Illumina
    - Stacey Gabriel, Broad Inst.
    - Sean Hofherr, Fabric Genomics
  • Single-cell, Spatial, and in Situ Technologies
    Chair: Dina Finan, 10x Genomics
    - Carina Emery, Miltenyi Biotec
  • Combining WGS with a AI-based Tumor Enrichment Method
    Chair: Asaf Zviran, C2I
  • Multi-omics Approaches Supporting Clinical Translation
    Chair: Cindy Lawley, Olink
    - Erin Smith, Takeda
    - Si Wu, Stanford
    - Christopher Whelan, J&J
  • Molecular Diagnosis New standard with NGS for Neurological and Infectious Conditions
    Chair: Scott Rabuka, DNA Genotek
    - Forrest Wright, Quadrant Laboratories
    - Frank Middleton, SUNY Upstate Medical University
  • PMWC Showcase
    - Josh Lauer, Ultime
    - Olivier Lucas, Oxford Nanopore
    - Lukasz Boryn, Ardigen

×

Add Names/PO on Receipt

Apply to Speak at PMWC Silicon Valley by JUL. 18TH

The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.

Contact Us:

Fields marked with an * are required 

Contact Us:

Fields marked with an * are required 

Discover What's Next in Precision Medicine!

Join our community today for the latest news, exclusive interviews, and unique insights from world-renowned speakers and experts


Contact Us:

Fields marked with an * are required 

Discount also depends on group size. The bigger group – the bigger discount.

Trouble Registering

Fields marked with an * are required

Stay Tuned For More Information.

Sign up for occasional updates on upcoming conferences, news, and other information. 

Get Updates:

Submit to Speak in the PMWC Showcase

Fields marked with an * are required